Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S15a pseudogene 36 (RPS15AP36) is a human pseudogene—an inactive, nonprotein-coding DNA segment derived from the parental ribosomal protein S15a gene. Unlike functional ribosomal protein genes, RPS15AP36 does not encode a functional protein and is not a recognized therapeutic target. Pseudogenes like RPS15AP36 are generated by inaccurate duplication or retrotransposition and typically accumulate disabling mutations that disrupt their coding potential. While a small subset of pseudogenes have regulatory RNA roles, there is no evidence RPS15AP36 is involved in disease, drug response, or functional molecular pathways[1][6][7][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S15a pseudogene 36 (RPS15AP36).